US Stock MarketDetailed Quotes

SLNO Soleno Therapeutics

Watchlist
  • 55.8600
  • +0.8000+1.45%
Close Nov 1 16:00 ET
  • 55.8600
  • 0.00000.00%
Post 20:01 ET
2.17BMarket Cap-30524P/E (TTM)

Soleno Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-217.12%-17.65M
-86.21%-12.53M
-20.01%-24.94M
-22.77%-6.31M
-36.00%-6.33M
-20.48%-5.57M
-5.75%-6.73M
25.17%-20.78M
25.06%-5.14M
13.87%-4.66M
Net income from continuing operations
-157.86%-21.85M
-156.08%-21.4M
-62.00%-38.99M
-105.91%-11.3M
-77.12%-10.86M
-26.02%-8.48M
-45.98%-8.36M
22.14%-24.07M
-93.99%-5.49M
24.67%-6.13M
Operating gains losses
----
----
706.67%182K
-47,100.00%-470K
32,750.00%653K
----
----
94.09%-30K
100.72%1K
98.21%-2K
Depreciation and amortization
1.02%494K
0.00%490K
-0.31%1.96M
0.20%489K
-0.41%490K
-0.61%489K
-0.41%490K
0.05%1.96M
-0.81%488K
0.00%492K
Other non cash items
320.20%1.71M
19.34%469K
819.19%3.04M
318.86%1.15M
432.84%1.09M
-40.99%406K
149.81%393K
4.74%-422K
83.90%-525K
-67.10%204K
Change In working capital
-598.64%-4.04M
1,600.88%1.94M
487.30%2.93M
852.96%1.91M
-1.01%98K
127.81%811K
111.90%114K
34.15%-756K
83.62%-253K
-88.04%99K
-Change in prepaid assets
579.55%299K
124.25%81K
-840.71%-837K
-194.64%-660K
3,666.67%113K
-80.00%44K
-392.98%-334K
181.29%113K
50.88%-224K
-98.72%3K
-Change in payables and accrued expense
-887.93%-4.83M
195.19%3.87M
192.12%1.54M
225.83%190K
-38.35%-570K
467.07%613K
238.62%1.31M
-177.32%-1.68M
80.57%-151K
-319.15%-412K
-Change in other current liabilities
-50.34%-436K
-208.70%-100K
640.43%762K
372.32%738K
40.51%222K
-835.48%-290K
2,966.67%92K
-10.16%-141K
0.00%-271K
-36.55%158K
-Change in other working capital
107.88%923K
-100.10%-1.91M
54.17%1.46M
316.54%1.64M
-4.86%333K
32.93%444K
-633.85%-954K
441.88%947K
585.19%393K
122.93%350K
Cash from discontinued investing activities
Operating cash flow
-217.12%-17.65M
-86.21%-12.53M
-20.01%-24.94M
-22.77%-6.31M
-36.00%-6.33M
-20.48%-5.57M
-5.75%-6.73M
25.17%-20.78M
25.06%-5.14M
13.87%-4.66M
Investing cash flow
Cash flow from continuing investing activities
-120.92M
-115.24M
0
0
0
0
0
40.91%-13K
53.85%-6K
0
Net PPE purchase and sale
---8K
---11K
--0
--0
--0
--0
--0
40.91%-13K
53.85%-6K
--0
Net investment purchase and sale
---120.91M
---115.23M
----
----
----
--0
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
---120.92M
---115.24M
--0
--0
--0
--0
--0
40.91%-13K
53.85%-6K
--0
Financing cash flow
Cash flow from continuing financing activities
795.36%152.75M
938K
1,177.46%180.02M
123.56M
11,420.76%39.4M
6,149.65%17.06M
0
11,109.38%14.09M
0
342K
Net common stock issuance
----
----
877.15%137.86M
--117.93M
739.77%2.87M
----
----
--14.11M
--0
--342K
Proceeds from stock option exercised by employees
--3.16M
--938K
--42.16M
--5.63M
--36.53M
--0
--0
--0
--0
----
Net other financing activities
----
----
----
----
----
----
----
86.67%-16K
--0
--0
Cash from discontinued financing activities
Financing cash flow
795.36%152.75M
--938K
1,177.46%180.02M
--123.56M
11,420.76%39.4M
6,149.65%17.06M
--0
11,109.38%14.09M
--0
--342K
Net cash flow
Beginning cash position
444.16%42.85M
1,062.04%169.68M
-31.46%14.6M
165.49%52.44M
-19.52%19.37M
-72.82%7.87M
-31.46%14.6M
-56.72%21.3M
-29.92%19.75M
-28.37%24.07M
Current changes in cash
23.34%14.18M
-1,785.17%-126.83M
2,413.92%155.08M
2,377.02%117.24M
866.55%33.07M
334.14%11.49M
-187.72%-6.73M
76.00%-6.7M
25.17%-5.15M
20.27%-4.31M
End cash Position
194.42%57.02M
444.16%42.85M
1,062.04%169.68M
1,062.04%169.68M
165.49%52.44M
-19.52%19.37M
-72.82%7.87M
-31.46%14.6M
-31.46%14.6M
-29.92%19.75M
Free cash flow
-217.27%-17.66M
-86.37%-12.54M
-19.94%-24.94M
-22.63%-6.31M
-36.00%-6.33M
-20.29%-5.57M
-5.75%-6.73M
25.18%-20.79M
25.12%-5.15M
13.95%-4.66M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -217.12%-17.65M-86.21%-12.53M-20.01%-24.94M-22.77%-6.31M-36.00%-6.33M-20.48%-5.57M-5.75%-6.73M25.17%-20.78M25.06%-5.14M13.87%-4.66M
Net income from continuing operations -157.86%-21.85M-156.08%-21.4M-62.00%-38.99M-105.91%-11.3M-77.12%-10.86M-26.02%-8.48M-45.98%-8.36M22.14%-24.07M-93.99%-5.49M24.67%-6.13M
Operating gains losses --------706.67%182K-47,100.00%-470K32,750.00%653K--------94.09%-30K100.72%1K98.21%-2K
Depreciation and amortization 1.02%494K0.00%490K-0.31%1.96M0.20%489K-0.41%490K-0.61%489K-0.41%490K0.05%1.96M-0.81%488K0.00%492K
Other non cash items 320.20%1.71M19.34%469K819.19%3.04M318.86%1.15M432.84%1.09M-40.99%406K149.81%393K4.74%-422K83.90%-525K-67.10%204K
Change In working capital -598.64%-4.04M1,600.88%1.94M487.30%2.93M852.96%1.91M-1.01%98K127.81%811K111.90%114K34.15%-756K83.62%-253K-88.04%99K
-Change in prepaid assets 579.55%299K124.25%81K-840.71%-837K-194.64%-660K3,666.67%113K-80.00%44K-392.98%-334K181.29%113K50.88%-224K-98.72%3K
-Change in payables and accrued expense -887.93%-4.83M195.19%3.87M192.12%1.54M225.83%190K-38.35%-570K467.07%613K238.62%1.31M-177.32%-1.68M80.57%-151K-319.15%-412K
-Change in other current liabilities -50.34%-436K-208.70%-100K640.43%762K372.32%738K40.51%222K-835.48%-290K2,966.67%92K-10.16%-141K0.00%-271K-36.55%158K
-Change in other working capital 107.88%923K-100.10%-1.91M54.17%1.46M316.54%1.64M-4.86%333K32.93%444K-633.85%-954K441.88%947K585.19%393K122.93%350K
Cash from discontinued investing activities
Operating cash flow -217.12%-17.65M-86.21%-12.53M-20.01%-24.94M-22.77%-6.31M-36.00%-6.33M-20.48%-5.57M-5.75%-6.73M25.17%-20.78M25.06%-5.14M13.87%-4.66M
Investing cash flow
Cash flow from continuing investing activities -120.92M-115.24M0000040.91%-13K53.85%-6K0
Net PPE purchase and sale ---8K---11K--0--0--0--0--040.91%-13K53.85%-6K--0
Net investment purchase and sale ---120.91M---115.23M--------------0--0------------
Cash from discontinued investing activities
Investing cash flow ---120.92M---115.24M--0--0--0--0--040.91%-13K53.85%-6K--0
Financing cash flow
Cash flow from continuing financing activities 795.36%152.75M938K1,177.46%180.02M123.56M11,420.76%39.4M6,149.65%17.06M011,109.38%14.09M0342K
Net common stock issuance --------877.15%137.86M--117.93M739.77%2.87M----------14.11M--0--342K
Proceeds from stock option exercised by employees --3.16M--938K--42.16M--5.63M--36.53M--0--0--0--0----
Net other financing activities ----------------------------86.67%-16K--0--0
Cash from discontinued financing activities
Financing cash flow 795.36%152.75M--938K1,177.46%180.02M--123.56M11,420.76%39.4M6,149.65%17.06M--011,109.38%14.09M--0--342K
Net cash flow
Beginning cash position 444.16%42.85M1,062.04%169.68M-31.46%14.6M165.49%52.44M-19.52%19.37M-72.82%7.87M-31.46%14.6M-56.72%21.3M-29.92%19.75M-28.37%24.07M
Current changes in cash 23.34%14.18M-1,785.17%-126.83M2,413.92%155.08M2,377.02%117.24M866.55%33.07M334.14%11.49M-187.72%-6.73M76.00%-6.7M25.17%-5.15M20.27%-4.31M
End cash Position 194.42%57.02M444.16%42.85M1,062.04%169.68M1,062.04%169.68M165.49%52.44M-19.52%19.37M-72.82%7.87M-31.46%14.6M-31.46%14.6M-29.92%19.75M
Free cash flow -217.27%-17.66M-86.37%-12.54M-19.94%-24.94M-22.63%-6.31M-36.00%-6.33M-20.29%-5.57M-5.75%-6.73M25.18%-20.79M25.12%-5.15M13.95%-4.66M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data